BeOne Medicines AG
BeOne Medicines's Climate Target Data Preview
As of 2024, BeOne Medicines has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into BeOne Medicines ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Intensity-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) per Kilogram (kg) of Unspecified Product Produced/Manufactured | Copy restricted. Please purchase to unlock this data.  a | 2026 |
Verified Sources Behind BeOne Medicines’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BeOne Medicines’s data sources below and access millions more through our Disclosure Search.
Insights into BeOne Medicines's Greenhouse Gas Emissions Pathways
As of 2024, BeOne Medicines has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a
Does BeOne Medicines have a target to reduce the emissions from its operations?
As of 2024, BeOne Medicines has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a
BeOne Medicines's most ambitious operational target is to reduce these emissions by 25% by 2026, compared to a baseline of 2.31 Metric Tonnes of CO2 equivalent (mtCO2e) per Kilogram (kg) of Unspecified Product Produced/Manufactured in 2021. a
As of 2024, BeOne Medicines is on track to meet its operational emissions reduction target, having achieved 60.6% of the planned reduction. a